BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Oct 26, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-10-24

Reporting Person: Wood Mark (VP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-24	Common Stock	M	83	$17.86	Acquired	20717	Direct
2011-10-24	Common Stock	M	937	$14.39	Acquired	21654	Direct
2011-10-24	Common Stock	M	833	$21.51	Acquired	22487	Direct
2011-10-24	Common Stock	S	1853	$33.3243	Disposed	20634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-24	Stock Option (right to bu) Common Stock	$17.86	M	83	Disposed	2018-12-16	Common Stock (83)	Direct
2011-10-24	Stock Option (right to buy) Common Stock	$14.39	M	937	Disposed	2019-05-11	Common Stock (937)	Direct
2011-10-24	Stock Option (right to buy) Common Stock	$21.51	M	833	Disposed	2020-05-11	Common Stock (833)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 20, 2011.

F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $32.99 to $33.47. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.

F4: Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.

F5: Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter.